Related references
Note: Only part of the references are listed.Polymer-based drug delivery systems under investigation for enzyme replacement and other therapies of lysosomal storage disorders
Marina Placci et al.
ADVANCED DRUG DELIVERY REVIEWS (2023)
Blood-brain barrier delivery for lysosomal storage disorders with IgG-lysosomal enzyme fusion proteins
William M. Pardridge
ADVANCED DRUG DELIVERY REVIEWS (2022)
Comparison between Nanoparticle Encapsulation and Surface Loading for Lysosomal Enzyme Replacement Therapy
Eameema Muntimadugu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Liposomal formulations for treating lysosomal storage disorders
Judit Tomsen-Melero et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders
Ambra Del Grosso et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Exosome- and extracellular vesicle-based approaches for the treatment of lysosomal storage disorders
Biao Lu et al.
ADVANCED DRUG DELIVERY REVIEWS (2022)
Altered blood-brain barrier transport of nanotherapeutics in lysosomal storage diseases
Melani Solomon et al.
JOURNAL OF CONTROLLED RELEASE (2022)
A method to improve quantitative radiotracing-based analysis of the in vivo biodistribution of drug carriers
Niksa Roki et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)
Zeta Potential and Colloidal Stability Predictions for Inorganic Nanoparticle Dispersions: Effects of Experimental Conditions and Electrokinetic Models on the Interpretation of Results
Daniel Jose Pochapski et al.
LANGMUIR (2021)
Role of lysosomes in physiological activities, diseases, and therapy
Ziqi Zhang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
FDA's Poly (Lactic-Co-Glycolic Acid) Research Program and Regulatory Outcomes
Yan Wang et al.
AAPS JOURNAL (2021)
Targeting lysosomes in human disease: from basic research to clinical applications
Mengdie Cao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer
Afrasim Moin et al.
DRUG DELIVERY (2021)
Intertwined mechanisms define transport of anti-ICAM nanocarriers across the endothelium and brain delivery of a therapeutic enzyme
Rachel L. Manthe et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Antibody stability: A key to performance - Analysis, influences and improvement
Hui Ma et al.
BIOCHIMIE (2020)
Phenomenology of the Initial Burst Release of Drugs from PLGA Microparticles
Jin Yoo et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles
Laura Rigon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Biodegradable PLGA Nanoparticles Restore Lysosomal Acidity and Protect Neural PC-12 Cells against Mitochondrial Toxicity
Jialiu Zeng et al.
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH (2019)
Lysosomes as a therapeutic target
Srinivasa Reddy Bonam et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends
Tengteng Wang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Brain-targeted enzyme-loaded nanoparticles: A breach through the blood-brain barrier for enzyme replacement therapy in Krabbe disease
Ambra Del Grosso et al.
SCIENCE ADVANCES (2019)
Current developments and applications of microfluidic technology toward clinical translation of nanomedicines
Dongfei Liu et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Cross-Linked Enzyme Aggregates as Versatile Tool for Enzyme Delivery: Application to Polymeric Nanoparticles
Marianna Galliani et al.
BIOCONJUGATE CHEMISTRY (2018)
Colloidal stability as a determinant of nanoparticle behavior in the brain
Chad Curtis et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2018)
Suggested Procedures for the Reproducible Synthesis of Poly(d,l-lactide-co-glycolide) Nanoparticles Using the Emulsification Solvent Diffusion Platform
Shadabul Haque et al.
CURRENT NANOSCIENCE (2018)
Targeting superoxide dismutase to endothelial caveolae profoundly alleviates inflammation caused by endotoxin
Vladimir V. Shuvaev et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Harnessing Lysosomal pH through PLGA Nanoemulsion as a Treatment of Lysosomal-Related Neurodegenerative Diseases
Geoffrey Prevot et al.
BIOCONJUGATE CHEMISTRY (2018)
Lysosomal storage diseases
Frances M. Platt et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories
Yihan Xu et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2017)
Enhanced Delivery and Effects of Acid Sphingomyelinase by ICAM-1-Targeted Nanocarriers in Type B Niemann-Pick Disease Mice
Carmen Garnacho et al.
MOLECULAR THERAPY (2017)
Nanoparticles restore lysosomal acidification defects: Implications for Parkinson and other lysosomal-related diseases
Mathieu Bourdenx et al.
AUTOPHAGY (2016)
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
Daniel Bobo et al.
PHARMACEUTICAL RESEARCH (2016)
In-vitro degradation of PLGA nanoparticles in aqueous medium and in stem cell cultures by monitoring the cargo fluorescence spectrum
N. Rescignano et al.
POLYMER DEGRADATION AND STABILITY (2016)
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders
Marika Salvalaio et al.
PLOS ONE (2016)
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts
Tancini Brunella et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2015)
Investigation of factors influencing the hydrolytic degradation of single PLGA microparticles
Hakan Keles et al.
POLYMER DEGRADATION AND STABILITY (2015)
Ultra-High Throughput Synthesis of Nanoparticles with Homogeneous Size Distribution Using a Coaxial Turbulent Jet Mixer
Jong-Min Lim et al.
ACS NANO (2014)
Emerging methods for the fabrication of polymer capsules
Jiwei Cui et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2014)
A novel approach to monitor intracellular degradation kinetics of poly(lactide-co-glycolide) nanoparticles by means of flow cytometry
Gabriela Romero et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
Biological Functionalization of Drug Delivery Carriers To Bypass Size Restrictions of Receptor-Mediated Endocytosis Independently from Receptor Targeting
Maria Ansar et al.
ACS NANO (2013)
Quantitative Detection of PLGA Nanoparticle Degradation in Tissues following Intravenous Administration
Abdul Khader Mohammad et al.
MOLECULAR PHARMACEUTICS (2013)
Brain-targeted polymeric nanoparticles: in vivo evidence of different routes of administration in rodents
Giovanni Tosi et al.
NANOMEDICINE (2013)
Intercellular Adhesion Molecule 1 Engagement Modulates Sphingomyelinase and Ceramide, Supporting Uptake of Drug Carriers by the Vascular Endothelium
Daniel Serrano et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Chemical and spatial analysis of protein loaded PLGA microspheres for drug delivery applications
A. Rafati et al.
JOURNAL OF CONTROLLED RELEASE (2012)
PLGA-based nanoparticles: An overview of biomedical applications
Fabienne Danhier et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Antibody Adsorption and Orientation on Hydrophobic Surfaces
Meredith E. Wiseman et al.
LANGMUIR (2012)
Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders
Silvia Muro
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2012)
A complete deficiency of Hyaluronoglucosaminidase 1 (HYAL1) presenting as familial juvenile idiopathic arthritis
Lisa Imundo et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems
Yao Fu et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Therapy for Lysosomal Storage Disorders
Michael Beck
IUBMB LIFE (2010)
Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers
Silvia Muro et al.
MOLECULAR THERAPY (2008)
Lysosomes: fusion and function
J. Paul Luzio et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Effects of acid exposure on the conformation, stability, and aggregation of monoclonal antibodies
Daisuke Ejima et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Limitations of enzyme replacement therapy: Current and future
J. E. Wraith
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
Synthesis and characterization of PLGA nanoparticles
Carlos E. Astete et al.
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION (2006)
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier
L Costantino et al.
JOURNAL OF CONTROLLED RELEASE (2005)
The cell biology of lysosomal storage disorders
AH Futerman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Delivery of therapeutic agents to the central nervous system: the problems and the possibilities
DJ Begley
PHARMACOLOGY & THERAPEUTICS (2004)
A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1
S Muro et al.
JOURNAL OF CELL SCIENCE (2003)
Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo
JE Schnitzer
ADVANCED DRUG DELIVERY REVIEWS (2001)
Variable clinical presentation in lysosomal storage disorders
M Beck
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices
RA Jain
BIOMATERIALS (2000)
Share Paper
